<?xml version="1.0" encoding="UTF-8"?>
<p>Altogether, the increased presence of CVD holds true for COVID-19 patients, most notably among those with severe disease. Currently, the mechanism of these associations remains unclear. Potential explanations include CVD being more prevalent in those with advancing age, a functionally impaired immune system, increased levels of ACE2, or a predisposition to COVID-19 for those with CVD [
 <xref rid="B44-jcm-09-01407" ref-type="bibr">44</xref>].
</p>
